Complete Revascularization Versus Culprit-Lesion-Only PCI in STEMI Patients With Diabetes and Multivessel Coronary Artery Disease: Results From the COMPLETE Trial.
Zardasht OqabVijay KunadianDavid A WoodRobert F StoreySunil V RaoRoxana MehranNatalia Pinilla-EcheverriThenmozhi ManiRobert H BooneSaleem KassamMatthias BossardSamer MansourWarren BallMatthew SibbaldNicholas ValettasRaul MorenoPhillippe Gabriel StegJohn A CairnsShamir R MehtaPublished in: Circulation. Cardiovascular interventions (2023)
Among patients presenting with STEMI and multivessel disease, the benefit of complete revascularization over a culprit-lesion-only percutaneous coronary intervention strategy was consistent regardless of the presence or absence of diabetes.
Keyphrases
- percutaneous coronary intervention
- coronary artery disease
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- coronary artery bypass grafting
- acute myocardial infarction
- antiplatelet therapy
- acute coronary syndrome
- coronary artery bypass
- type diabetes
- atrial fibrillation
- cardiovascular events
- clinical trial
- study protocol
- cardiovascular disease
- heart failure
- phase iii
- adipose tissue
- insulin resistance
- phase ii
- transcatheter aortic valve replacement